Evidence map›Paper›PMID 42141110›Full record

ArticleScientific reports2026

Small CD63 + CD81+ extracellular vesicles induce autophagy via the FOXO3a pathway in pancreatic cancer cells during starvation.

Daniel Grasso, Maximiliano A Diaz, Laura Sobrado, Valentín Yzetta, Marcela A Cucher, Maria L Cerutti, Daniela L Papademetrio, Elida Alvarez, Maria Noé Garcia

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel GrassoFaculty of Pharmacy and Biochemistry, Institute of Humoral Immunity Studies (IDEHU), CONICET, University of Buenos Aires, Buenos Aires, Argentina. dgrasso@ffyb.uba.ar.
Maximiliano A DiazFaculty of Pharmacy and Biochemistry, Institute of Humoral Immunity Studies (IDEHU), CONICET, University of Buenos Aires, Buenos Aires, Argentina.
Laura SobradoFaculty of Pharmacy and Biochemistry, Institute of Humoral Immunity Studies (IDEHU), CONICET, University of Buenos Aires, Buenos Aires, Argentina.
Valentín YzettaFaculty of Pharmacy and Biochemistry, Institute of Humoral Immunity Studies (IDEHU), CONICET, University of Buenos Aires, Buenos Aires, Argentina.
Marcela A CucherFaculty of Medicine, Institute of Research on Microbiology and Medical Parasitology (IMPAM), CONICET, University of Buenos Aires AR, Buenos Aires, Argentina.
Maria L CeruttiCenter for Protein Engineering and Redesign (CRIP), School of Bio and Nanotechnologies, CONICET, National University of San Martín AR, Buenos Aires, Argentina.
Daniela L PapademetrioFranco-Argentine Center for Pancreatic Cancer Research, Buenos Aires, Argentina.
Elida AlvarezFaculty of Pharmacy and Biochemistry, Institute of Humoral Immunity Studies (IDEHU), CONICET, University of Buenos Aires, Buenos Aires, Argentina.
Maria Noé GarciaFaculty of Pharmacy and Biochemistry, Institute of Humoral Immunity Studies (IDEHU), CONICET, University of Buenos Aires, Buenos Aires, Argentina. mnoegarcia@gmail.com.

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT-2020-SERIEA-02624Agencia Nacional de Promoción Científica y Tecnológica PICT-2021-GRF-TII-00050Consejo Nacional de Investigaciones Científicas y Técnicas PIP-2528Universidad de Buenos Aires 20020220100123BA
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC), the most common histological subtype of pancreatic cancer, is an aggressive malignancy expected to become the second leading cause of cancer-related deaths by 2040. A hallmark of PDACs is the highly desmoplastic and hypovascularized nature of its microenvironment, which enables PDAC cells to adapt and survive under conditions of low oxygen and nutrient deprivation through various cellular mechanisms. Among these processes, autophagy has emerged as a key response mechanism to cope with these adverse conditions. Consequently, a deeper understanding of the molecular events driving autophagy could pave the way for the development of new and more effective treatments for PDAC. In this context, we provide evidence of novel pathway mediated by extracellular vesicles (EVs) that promotes autophagy in a paracrine manner in PDAC cells in response to starvation. Our findings indicate that, under starvation conditions, EVs-associated tetraspanins, namely CD9, CD63 and CD81, mobilize towards domains-like structures within the plasma membrane of PDAC cells. Correspondingly, a specific release of small EVs (sEVs) is observed in the starved cells. Notably, sEVs derived from starved cells, but not those from cells at basal conditions, strongly induce the autophagy pathway in PDAC cells cultured with optimal nutritional media. Interestingly, this ability to induce autophagy is specific to CD63/CD81 double-positive sEVs and is effective even in non-tumoral pancreatic cells. This sEVs-mediated autophagy is, at least partially, mediated by the activation of the FOXO3a pathway. It is worth noting that, although EVs release returns to basal level after 1 h of recovery following starvation, these EVs retain a capacity to induce autophagy, suggesting a decupling between quantity and quality of secreted vesicles. Our results demonstrate that pancreatic cancer cells in nutrient-deprived environments release specific sEVs that, in turn, activate the FOXO3a pathway and autophagy flux in recipient cells.

Indexed as

AutophagyCarcinoma, Pancreatic DuctalExtracellular VesiclesForkhead Box Protein O3Pancreatic NeoplasmsTetraspanin 28Cell Line, TumorHumansSignal TransductionCD81 protein, humanForkhead Box Protein O3FOXO3 protein, humanTetraspanin 28AutophagyExtracellular vesiclesPancreatic cancer

Identifiers

PMID42141110
PMCPMC13369810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.